Milestone Scientific Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

false 0000855683 0000855683 2025-01-12 2025-01-12

 

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of

 

Date of report (Date of earliest event reported): January 12, 2025

 

 

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

(Address of principal executive offices)

 

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On January 12, 2025, Mr. Giandomenico Trombetta, a director of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he is resigning, effective immediately, as a director.

 

Mr. Trombetta indicated that his resignation is for personal reasons and the need to attended to other matters of an immediate nature that leave him unable to fulfill his responsibilities as a member of the board of the Company.

 

Mr. Trombetta indicated that his decision to leave the board of directors was not the result of any disagreements with the Company or the board of directors as to any matter relating to the Company’s operations, finances, policies, or practices.

 

 

 

 

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.